UK small-cap RNS · 7 May 2026
The key announcements of UK small & mid caps under £2bn on 7 May 2026 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 7 May | MJ Gleeson GLE | £167m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Luceco LUCE | £309m | Director dealing | Director/PDMR Shareholding | |
| 7 May | MJ Gleeson GLE | £167m | Director dealing | Director/PDMR Shareholding | |
| 7 May | LSL Property Services LSL | £249m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Renew Holdings RNWH | £759m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Trainline TRN | £733m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Chrysalis Investments Limited CHRY | £311m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Tatton Asset Management TAM | £397m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Secure Trust Bank STB | £267m | Director dealing | Director/PDMR Shareholding | |
| 7 May | Michelmersh Brick Holdings MBH | £68m | Director dealing | Grant of Options and PDMR dealing | |
| 7 May | GENinCode GENI | £4.7m | Director dealing | Grant of Share Options & PDMR Dealings
GENinCode Plc (AIM: GENI), the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer, announces that the Company has approved the grant of options over an aggregate of 83,847,292 new ordinary shares of 1 pence each in the … |